Inhibition of pulmonary eosinophilia and airway hyperresponsiveness in allergic mice by rolipram: Involvement of endogenously released corticosterone and catecholamines

British Journal of Pharmacology

Volumn 130, Issue 2, 2000, Pages 457-463

  Kung, T T ^a   Crawley, Y ^a   Luo, B ^a   Young, S ^a   Kreutner, W ^a   Chapman, R W ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

Author keywords

Adrenals; Airway; Catecholamines; Eosinophils; Hyperresponsiveness; Metyrapone; Phosphodiesterase 4 inhibitor; Rolipram

Indexed keywords

CATECHOLAMINE DERIVATIVE; CORTICOSTERONE; METYRAPONE; OVALBUMIN; PHOSPHODIESTERASE IV INHIBITOR; PROPRANOLOL; ROLIPRAM;

ADRENALECTOMY; ALLERGY; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRONCHUS HYPERREACTIVITY; CONTROLLED STUDY; EOSINOPHIL; EOSINOPHILIA; LOEFFLER PNEUMONIA; LUNG LAVAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; ANTIHYPERTENSIVE AGENTS; BRONCHIAL HYPERREACTIVITY; BRONCHOALVEOLAR LAVAGE; CATECHOLAMINES; CORTICOSTERONE; DRUG INTERACTIONS; HYPERSENSITIVITY; MALE; METYRAPONE; MICE; PHOSPHODIESTERASE INHIBITORS; PROPRANOLOL; PULMONARY EOSINOPHILIA; ROLIPRAM;

EID: 0034061874     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0703308     Document Type: Article

References (35)

1. CHAPMAN. R.W., SEHRING, S.J., GARLISI. C.G., FALCONE, A., KUNG, T.T., STELTS, D., MINNICOZZI, M., JONES, H., UMLAND, S., EGAN, R.W. & KREUTNER, W. (1998). Anti-inflammatory activity of inhaled mometasone furoate in allergic mice. Arzneim.-Forsch. Drug Res., 48, 384-391.
2. CHENG, J.B., WATSON, J.W., PAZOLES, C.J., FSKRA, J.D., GRIFFITHS, R.J., COHAN, V.L., TURNER, C.R., SHOWELL, H.J. & PETTIPHER, E.R. (1997). The phosphodiesterase type 4 (PDE4) inhibitor CP-80, 633 elevates plasma cyclic AMP levels and decreases tumor necrosis factor-α (TNF-α) production in mice: effect of adrenalectomy. J. Pharmacol. Exp. Ther., 280, 621-626.
3. CROCKER, C., TOWNLEY, R.G. & KHAN, M.M. (1996). Phosphodiesterase inhibitors suppress proliferation of peripheral blood mononuclear cells and interleukin-4 and-5 secretion by human T-helper type 2 cells. Immunopharmacology, 31, 223-225.
4. DANAHAY, H. & BROADLEY, K.J. (1997). Effect of inhibitors of phosphodiesterase, on antigen-induced bronchial hyperreactivity in conscious sensitized guinea pigs and airway leukocyte infiltration. Br. J. Pharmacol., 120, 289-297.
5. DEBIE, T.T., HESSEL, E.M., VAN ARK, I., VAN ESCH, B., HOFMAN, G., NIJKAMP, F.P. & VAN OOSTERHOUT, A.J.M. (1996). Effect of dexamethasone and endogenous corticosterone on airway hyperresponsiveness and eosinophilia in the mouse. Br. J. Pharmacol., 119, 1484-1490.
6. DENT, G., GIEMBYCZ, M.A., EVANS, P.M., RABE, K.F. & BARNES, P.J. (1994). Suppression of human eosinophil respiratory burst and cyclic AMP hydrolysis by inhibitors of type IV phosphodiesterase: interaction with the β-adrenoceptor agonist albuterol. J. Pharmacol. Exp. Ther., 271, 1167-1174.
7. ELENKOV, I.J., HASKÓ, G., KOVÁCS, K.J. & VIZI, E.S. (1995). Modulation of lipopolysaccharide-induced tumor necrosis factor-α production by selective α-and β adrenergic drugs in mice. J. Neuroimmunol., 61, 123-131.
8. GOZZARD, N., EL-HASHIM, A., HERD, C.M., BLAKE, S.M., HOLBROOK, M., HUGHES, B-., HIGGS, G.A. & PAGE, C.P. (1996). Effect of the glucocorticosteroid budesonide and a novel phosphodiesterase type 4 inhibitor CDP840 on antigen-induced airway responses in neonatally immunized rabbits. Br. J. Pharmacol., 118, 1201-1208.
9. GRISWOLD, D.E., WEBB, E.F., BRETON, J., WHITE, J.R., MARSHALL, P.L. & TORPHY, T.J. (1993). Effect of selective phosphodiesterase type IV inhibitor, rolipram, on fluid and cellular phase of inflammatory response. Inflammation, 17, 333-344.
10. HADLEY, A.J., KUMARI, M., COVER, P.O., OSBORNE, J., POYSER, R., FLACK, J.D. & BUCKINGHAM, J.C. (1996). Stimulation of the hypothalamo-pituitary-adrenal axis in the rat by the type 4 phosphodiesterase (PDE-4) inhibitor, denbufylline. Br. J. Pharmacol., 119, 463-470.
11. HESSEL, E.M., VAN OOSTERHOUT, A.J.M., HOFSTRA, C.L., DF BIE, J.J., GARSSEN, J., VAN LOVEREN, H., VERHEYEN, A.K.C.P., SAVELKOUL, H.F.J. & NUKAMP, F.P. (1995). Bronchoconstriction and airway hyperresponsiveness after ovalbumin inhalation in sensitized mice. Eur. J. Pharmacol., 294, 401-412.
12. HIGBEE, M.D., KUMAR, M. & GALANT, S.P. (1982). Stimulation of endogenous catecholamine release by theophylline: a proposed additional mechanism of action for theophylline effects. J. Allergy Clin. Imnnmol., 70, 377-382.
13. HOLBROOK, M., GOZZARD, N., JAMES, T., HIIGGS, G. & HUGHES, B. (1996). Inhibition of bronchospasm and ozone-induced airway hyperresponsiveness in the guinea pig by CDP840, a novel phosphodiesterase type 4 inhibitor. Br. J. Pharmacol., 118, 1192-1200.
14. HOWELL, R.E., JENKINS, L.P. & HOWELL, D.E. (1995). Inhibition of lipopolysaccharide-induced pulmonary edema by isozyme-selective phosphodiesterase inhibitors in guinea pigs. J. Pharmacol. Exp. Ther., 275, 703-709.
15. HUGHES, B., HOWAT, D., LISLE, H., HOLBROOK, M., JAMES, T., GOZZARD, N., BLEASE, K., HUGHES, P., KINGABY, R., WARRELLOW, G., ALEXANDER, R., HEAD, J., BOYD, E., EATON, M., PERRY, M., WALES, M., SMITH, B., OWENS, R., CATTERALL, C., LUMB, S., RUSSELL, A., ALLEN, R., MERRIMAN, M., BLOXHAM, M. & HIGGS, G. (1996). The inhibition of antigen-induced eosinophilia and bronchoconstriction by CDP840, a novel stereo-selective inhibitor of phosphodiesterase type-4. Br. J. Pharmacol., 118, 1183-1191.
16. KAMBAYASHI, T., JACOB, C.O., ZHOU, D., MAZUREK, N., FONG, M. & STRASSMANN, G. (1995). Cyclic nucleotide phosphodiesterase type IV participates in the regulation of IL-10 and in the subsequent inhibition of TNF-α and IL-6 release by endotoxin-stimulated macrophages. J. Immunol., 155, 4909-4916.
17. KAY, A.B. (1991). Asthma and inflammation. J. Allergy Clin. Immunol., 87, 893-910.
18. KUMARI, M., COVER, P.O., POYSER, R.H. & BUCKINGHAM, J.C. (1997). Stimulation of the hypothalamo-pituitary-adrenal axis in the rat by three selective type-4 phosphodiesterase inhibitors: in vitro and in vivo studies. Br. J. Pharmacol., 121, 459-468.
19. KUNG, T.T., JONES, H., ADAMS III G.K., UMLAND, S.P., KREUTNER, W., EGAN, R.W., CHAPMAN, R.W. & WATNICK, A.S. (1994). Characterization of murine model of allergic pulmonary inflammation. Int. Arch. Allergy Immunol., 105, 83-90.
20. LILLY, C.M., CHAPMAN, R.W., SEHRING, S.J., MAUSER, P., EGAN, R.W. & DRAZEN, J.M. (1996). Effects of interleukin 5-induced pulmonary eosinophilia on airway reactivity in the guinea pig. Am. J. Physiol., 270, L368-L375.
21. MAUSER, P.J., PITMAN, A., WITT, A., FERNANDEZ, X., ZURCHER, J., KUNG, T., JONES, H., WATNICK, A.S., EGAN, R.W., KREUTNER, W. & ADAMS III G.K. (1993). Inhibitory effect of the TRFK-5 anti-IL-5 antibody in a guinea pig model of asthma. Am. Rev. Respir. Dis., 148, 1623-1627.
22. PALFREYMAN, M.N. & SOUNESS, J.E. (1996). Phosphodiesterase type IV inhibitors. In Progress in Medicinal Chemistry, ed. Ellis, G.P. & Luscombe, D.K., Vol. 33, pp. 1-52. Amsterdam: Elsevier Science BV.
23. PETTIPHER, E.R., ESKRA, J.D. & LABASI, J.M. (1997). The inhibitory effect of rolipram on TNF-α production in mouse blood ex vivo is dependent upon the release of corticosterone and adrenaline. Cytokine, 9, 582-586.
24. PETTIPHER, E.R., LABASI, J.M., SALTER, E.D., STAM, E.J., CHENG, J.B. & GRIFFITHS, R.J. (1996). Regulation of tumor necrosis factor production by adrenal hormones in vivo: insights into the anti-inflammatory activity of rolipram. Br. J. Pharmacol., 117, 15430-1534.
25. RAEBURN, D. & KARLSSON, J.A. (1993). Effects of isoenzyme-selective inhibitors of cyclic nucleotide phosphodiesterase on microvascular leak in guinea pig airways in vivo. J. Pharmacol. Exp. Ther., 267, 1147-1152.
26. SATO, J., HORI, S. & KAWAMURA, M. (1998). Effect of theophylline, caffeine and dimethylxanthines on endogenous glucocorticoid levels in mice. A possible mechanism of anti-inflammatory activity of theophylline. Pharm. Pharmacol. Commun., 4, 499-501.
27. SCHUESSLER, T.F. & BATES, J.H.T. (1995). A computer-controlled research ventilator for small animals: design and evaluation. IEEE Trans. Biomed. Eng., 42, 860-866.
28. TORPHY, T.J. (1998). Phosphodiesterase isozymes. Molecular targets for novel antiasthma agents. Am. J. Respir. Crit. Care Med., 157, 351-370.
29. TOURNOY, K.G., KIPS, J.C., SCHOU, C. & PAUWELS, R.A. (2000). Airway eosinophilia is nor a requirement for allergen-induced airway hyperresponsiveness. Clin. Exp. Allergy., 30, 79-85.
30. TURNER, C.R., ANDRESEN, C.J., SMITH, W.B. & WATSON, J.W. (1994). Effects of rolipram on responses to acute and chronic antigen exposure in monkeys. Am. J. Respir. Crit. Care Metd., 149, 1153-1159.
31. UNDEM, B.J., MEEKER, S.N. & CHEN, J. (1994). Inhibition of neurally mediated nonadrenergic, noncholinergic contractions of guinea pig bronchus by isozyme-selective phosphodiesterase inhibitors. J. Pharmacol. Exp. Ther., 271, 811-817.
32. UNDERWOOD, D.C., BOCHNOLOICZ, S., OSBORN, R.R., KOTZER, C.J., LUTTMANN, M.A., HAY, D.W.P., GORYCKI, P.D. CHRISTENSEN, S.B. & TORPHY, T.J. (1998). Antiasthmatic activity of the second-generation phosphodiesterase 4 (PDE 4) inhibitor SB 207499 (Airflo) in the guinea pig. J. Pharmacol. Exp. Ther., 287, 988-995.
33. UNDERWOOD, D.C., KOTZER, C.J., BOCHNOWICZ, S., OSBORN, R.R., LUTTMAN, M.A., HAY, D.W.P. & TORPHY, T.J. (1994). Comparison of phosphodiesterase III, IV and dual III/IV inhibitors on bronchospasm and pulmonary eosinophil influx in guinea pigs. J. Pharmacol. Exp. Ther., 270, 250-259.
34. UNDERWOOD, D.C., MATTHEWS, J.K., OSBORN, R.R., BOCHNOWICZ, S. & TORPHY, T.J. (1997). The influence of endogenous catecholamines on the inhibitory effects of rolipram against early-and late-phase response to antigen in the guinea pig. J. Pharmacol. Exp. Ther., 280, 210-219.
35. VESTAL, R.E., EIRIKSSON, C.E., MUSSER, B., OZAKI, L.K. & HALTER, J.B. (1983). Effect of intravenous aminophylline on plasma levels of catecholamines and related cardiovascular and metabolic responses in man. Circulation, 67, 162-171.